STTR Phase II: Scaling the Purification of Mycosporine-like Amino Acids to Replace Chemical Ultraviolet (UV) Filters and Protect Human and Environmental Health.
STTR 第二阶段:扩大类菌孢素氨基酸的纯化,以取代化学紫外线 (UV) 过滤器并保护人类和环境健康。
基本信息
- 批准号:2222582
- 负责人:
- 金额:$ 93.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Cooperative Agreement
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-15 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The broader impact of this Small Business Technology Transfer (STTR) Phase II project will be to bring a new class of full spectrum Ultraviolet A and B (UVA and UVB) protective materials to market. Current chemical sunscreen ingredients raise health concerns for consumers. Additionally, some ingredients are banned for causing potential damage to coral reef ecosystems. Consumers increasingly want products that are safe for them and for the planet, and that are aesthetically pleasing. This project will explore ways to meet the growing demand for better sunscreen ingredients that are produced sustainably. This team will investigate methods to cost-effectively extract naturally-occurring materials from photosynthetic bacteria that can replace current chemical and mineral sunscreen active ingredients. These will also replace a significant portion of the UV filter ingredients. Sunscreens and other related products that might use these naturally occurring, safe, and effective ingredients will help people reduce UV damage to their skin and help reduce skin cancer (including deadly melanoma) and ameliorate skin aging. The project supports the US economy by creating jobs in the algae biotechnology field and in the cosmetic industry including testing, manufacturing, distribution, and sales. The technical innovation at the core of this proposal is to improve the yield and reduce the cost of extracting mycosporine-like amino acids (MAAs) from a complex mixture of compounds contained within cyanobacterial cells (or other MAA producing organisms). Small volumes of MAAs are currently obtained using expensive and hazardous solvents and expensive equipment. The innovation is focused on the use of synthetic nucleotides (aptamers) to selectively bind to the MAAs and purify them from a cell lysate. Mycosporine-like amino acids arose on early Earth to protect microbes from harmful UV radiation. Their prevalence and longevity substantiate their value in protecting cells from UV radiation and other forms of oxidative stress. Their presence in the Earth’s oceans for millennia speaks to their safety in marine ecosystems and suggests their safety for use on human skin; Safety will be verified using standard pre-clinical tests. Technical hurdles include the isolation and identification of the specific MAAs produced, identifying aptamers that are highly specific for the MAAs produced, determining MAA yield from several purification processes and assessing process scalability. These data will be compared to other isolation techniques (filtration and chromatography) to assess comparative yields and economic performance.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
这一小型企业技术转让(STTR)第二阶段项目的更广泛影响将是将一类新的全光谱紫外线A和B(UVA和UVB)防护材料推向市场。 目前的化学防晒成分引起了消费者的健康担忧。 此外,一些成分因对珊瑚礁生态系统造成潜在损害而被禁止。消费者越来越希望产品对他们和地球都是安全的,而且美观。该项目将探索如何满足对可持续生产的更好防晒成分日益增长的需求。 该团队将研究从光合细菌中经济有效地提取天然材料的方法,这些材料可以取代目前的化学和矿物防晒活性成分。 这些也将取代相当一部分的紫外线过滤剂成分。防晒霜和其他可能使用这些天然、安全和有效成分的相关产品将帮助人们减少紫外线对皮肤的伤害,并有助于减少皮肤癌(包括致命的黑色素瘤)和改善皮肤老化。该项目通过在藻类生物技术领域和化妆品行业(包括测试、制造、分销和销售)创造就业机会来支持美国经济。该提议的核心技术创新是提高产率并降低从蓝藻细胞(或其他产生MAA的生物体)中含有的化合物的复杂混合物中提取类菌孢菌素氨基酸(MAA)的成本。小体积的MAA目前使用昂贵且危险的溶剂和昂贵的设备获得。创新的重点是使用合成核苷酸(适体)选择性地结合到MAA上,并从细胞裂解物中纯化它们。类菌孢素氨基酸在早期地球上出现,以保护微生物免受有害的紫外线辐射。它们的流行和寿命证实了它们在保护细胞免受紫外线辐射和其他形式的氧化应激方面的价值。它们在地球海洋中存在了数千年,说明它们在海洋生态系统中是安全的,并表明它们在人类皮肤上使用是安全的;安全性将通过标准的临床前测试进行验证。技术障碍包括分离和鉴定所产生的特定MAA,鉴定对所产生的MAA具有高度特异性的适体,确定来自几种纯化工艺的MAA产率以及评估工艺可扩展性。这些数据将与其他分离技术(过滤和色谱)进行比较,以评估比较产率和经济性能。该奖项反映了NSF的法定使命,并被认为值得通过使用基金会的知识价值和更广泛的影响审查标准进行评估。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Smernoff其他文献
David Smernoff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Smernoff', 18)}}的其他基金
STTR Phase I: Purification of Mycosporine-like Amino Acids using Aptamers
STTR 第一阶段:使用适体纯化类菌孢菌素氨基酸
- 批准号:
1940352 - 财政年份:2020
- 资助金额:
$ 93.76万 - 项目类别:
Standard Grant
相似国自然基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark
Supercooled Phase Transition
- 批准号:24ZR1429700
- 批准年份:2024
- 资助金额:0.0 万元
- 项目类别:省市级项目
ATLAS实验探测器Phase 2升级
- 批准号:11961141014
- 批准年份:2019
- 资助金额:3350 万元
- 项目类别:国际(地区)合作与交流项目
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
- 批准号:41802035
- 批准年份:2018
- 资助金额:12.0 万元
- 项目类别:青年科学基金项目
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究
- 批准号:61675216
- 批准年份:2016
- 资助金额:60.0 万元
- 项目类别:面上项目
基于Phase-type分布的多状态系统可靠性模型研究
- 批准号:71501183
- 批准年份:2015
- 资助金额:17.4 万元
- 项目类别:青年科学基金项目
纳米(I-Phase+α-Mg)准共晶的临界半固态形成条件及生长机制
- 批准号:51201142
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
连续Phase-Type分布数据拟合方法及其应用研究
- 批准号:11101428
- 批准年份:2011
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
D-Phase准晶体的电子行为各向异性的研究
- 批准号:19374069
- 批准年份:1993
- 资助金额:6.4 万元
- 项目类别:面上项目
相似海外基金
STTR Phase II: Fabrication and Structural Testing of a 3D Concrete Printed Anchor for Floating Offshore Wind
STTR 第二阶段:用于浮动海上风电的 3D 混凝土打印锚的制造和结构测试
- 批准号:
2333306 - 财政年份:2024
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Optimized manufacturing and machine learning based automation of Endothelium-on-a-chip microfluidic devices for drug screening applications.
STTR 第二阶段:用于药物筛选应用的片上内皮微流体装置的优化制造和基于机器学习的自动化。
- 批准号:
2332121 - 财政年份:2024
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Earth-abundant catalyst for power-to-liquids chemical production at the kiloton scale
STTR 第二阶段:地球储量丰富的催化剂,用于千吨级电力转化为液体的化学生产
- 批准号:
2304275 - 财政年份:2024
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Dermatologist-level detection of suspicious pigmented skin lesions from high-resolution full-body images
STTR II 期:通过高分辨率全身图像对可疑色素性皮肤病变进行皮肤科医生级别的检测
- 批准号:
2335086 - 财政年份:2024
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Thermal Imaging, Augmentation of Microwave Energy in Various Tissues and Chronic Safety
STTR 第二阶段:热成像、增强各种组织中的微波能量和长期安全性
- 批准号:
2301440 - 财政年份:2024
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Nanomaterial-based Residual Active Disinfectant for Decreasing Surface Acquired Infections
STTR 第二阶段:基于纳米材料的残留活性消毒剂,用于减少表面获得性感染
- 批准号:
2208717 - 财政年份:2023
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Stem Cell Delivery in Microscopic Hydrogel Droplets for Faster and More Complete Healing of Equine Tendon and Ligament Injuries
STTR 第二阶段:以微小水凝胶液滴形式输送干细胞,以更快、更完全地治愈马肌腱和韧带损伤
- 批准号:
2304324 - 财政年份:2023
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Development of a Smart Remote Health Management System for Patients with Kidney Disease
STTR二期:为肾病患者开发智能远程健康管理系统
- 批准号:
2243718 - 财政年份:2023
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Body fluid identification for forensic purposes using Raman spectroscopy
STTR 第二阶段:使用拉曼光谱法进行体液鉴定
- 批准号:
2304318 - 财政年份:2023
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement
STTR Phase II: Accurate Fetal Health Monitoring During Labor and Delivery
STTR 第二阶段:临产和分娩过程中准确的胎儿健康监测
- 批准号:
2233238 - 财政年份:2023
- 资助金额:
$ 93.76万 - 项目类别:
Cooperative Agreement